Tag: Hēlo thrombectomy system
Endovascular Engineering’s ENGULF pivotal trial completes patient enrolment
Endovascular Engineering (E2) has completed patient enrolment in the pivotal cohort of its ENGULF trial, involving the Hēlo pulmonary embolism (PE) thrombectomy system.
The investigational...
E2 shares positive initial results from use of Hēlo system for...
Endovascular Engineering (E2) has announced positive initial results from its ENGULF study, demonstrating successful outcomes among the first 15 patients evaluated in the trial...
